-
EP1893230
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1893230
| EP1893230 - USE OF MODIFIED FACTOR VII FOR TREATING BLEEDING [Right-click to bookmark this link] | Status | The application has been refused Status updated on 22.07.2011 Database last updated on 20.05.2024 | Most recent event Tooltip | 22.07.2011 | Refusal of application | published on 24.08.2011 [2011/34] | Applicant(s) | For all designated states Bayer HealthCare LLC 800 Dwight Way Berkeley CA 94710 / US | [2008/52] |
| Former [2008/10] | For all designated states Maxygen Holdings Ltd. c/o Close Brothers (Cayman) Limited, 103 South Church Street, P.O. Box 1034 GT Grand Cayman / KY | Inventor(s) | 01 /
RÖPKE, Mads Classensgade 47, 2.tv. DK-2100 Copenhagen / DK | 02 /
LATHROP, Stephanie 130 Brenton Court Mountain View, CA 94063 / US | [2008/10] | Representative(s) | Hallybone, Huw George Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2009/10] | Hallybone, Huw George Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
| Former [2008/10] | Salka, Jeffrey Maxygen ApS, Agern Allé 1, Danish Science Park 2970 Hoersholm / DK | Application number, filing date | 06722968.2 | 25.04.2006 | [2008/10] | WO2006DK50016 | Priority number, date | US20050674815P | 26.04.2005 Original published format: US 674815 P | [2008/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006114105 | Date: | 02.11.2006 | Language: | EN | [2006/44] | Type: | A2 Application without search report | No.: | EP1893230 | Date: | 05.03.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.11.2006 takes the place of the publication of the European patent application. | [2008/10] | Search report(s) | International search report - published on: | EP | 09.08.2007 | Classification | IPC: | A61K38/48, A61K47/48, A61P7/04, A61P41/00 | [2008/10] | CPC: |
A61K38/4846 (EP,US);
A61K47/60 (EP,US);
A61P41/00 (EP);
A61P7/04 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/10] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | VERWENDUNG VON MODIFIZIERTEM FAKTOR VII ZUR BEHANDLUNG VON BLUTUNGEN | [2008/10] | English: | USE OF MODIFIED FACTOR VII FOR TREATING BLEEDING | [2008/10] | French: | UTILISATION DE FACTEUR VII MODIFIE POUR TRAITER LES SAIGNEMENTS | [2008/10] | Entry into regional phase | 05.11.2007 | National basic fee paid | 05.11.2007 | Designation fee(s) paid | 05.11.2007 | Examination fee paid | Examination procedure | 05.11.2007 | Amendment by applicant (claims and/or description) | 05.11.2007 | Examination requested [2008/10] | 30.12.2009 | Despatch of a communication from the examining division (Time limit: M06) | 16.08.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 26.10.2010 | Reply to a communication from the examining division | 01.04.2011 | Cancellation of oral proceeding that was planned for 07.04.2011 | 07.04.2011 | Date of oral proceedings (cancelled) | 08.04.2011 | Despatch of communication that the application is refused, reason: substantive examination [2011/34] | 18.04.2011 | Application refused, date of legal effect [2011/34] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.12.2009 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 26.10.2010 | Request for further processing filed | 26.10.2010 | Full payment received (date of receipt of payment) Request granted | 11.11.2010 | Decision despatched | Fees paid | Renewal fee | 18.03.2008 | Renewal fee patent year 03 | 29.04.2009 | Renewal fee patent year 04 | 26.04.2010 | Renewal fee patent year 05 | 25.04.2011 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AP]WO2005123916 (NOVO NORDISK HEALTHCARE AG [CH], et al) [AP] 1-26 * see claims 1-8, page 18 lines 7-14, page 11 line 32 to page 12 line 15 *; | [X]WO2004083361 (MAXYGEN HOLDINGS LTD, et al) [X] 1-26 * claims 1, 19-38, pages 26-27, page 17 line 13 to page 18 line 28, page 30 line 22 to page 31 line 28 *; | [X]WO2004111242 (MAXYGEN HOLDINGS LTD, et al) [X] 1-26 * abstract, claims 28-38 and 65-68, pages 28-29 and 34-35 *; | [X]WO0158935 (MAXYGEN APS [DK]) [X] 17-21 * claims 1 and 31-50, pages 29-30 and page 51 *; | [X]WO2004029091 (MAXYGEN APS [DK], et al) [X] 1-26 * abstract, claims 1-2, 13-35 and 58-61, pages 33-36 and pages 50-53 *; | [X]WO03093465 (MAXYGEN APS [DK], et al) [X] 1-26 * claims 1-18, 29-40 and 51, pages 31-34 * |